A new patient-centred model for discovering and accelerating the translation of new medicines
Our Discovery Syndicates will promote new ways of translating the best science into high-value diagnostics, biomarkers and medicines. Anchored by the relevant medical research charity, they will build disease focused consortia, centred around real patient needs.
Discovery Syndicates will enable coordination, planning and delivery of collaborative research, to de-risk new promising assets and accelerate their translation to the clinic.
Through the partnership of the leading medical research charity and the Medicines Discovery Catapult, each Syndicate will bring together patients and clinical experts with innovators from industry (e.g. SMEs, pharma) and academia.
Discovery Syndicates will be underpinned by new frameworks to attract funding and investment to enable long-term focus and sustainability, and ultimately generate benefits and impact for all partners involved. The Medicines Discovery Catapult is actively working on the development of the Syndicate framework, while engaging with several medical research charities.
We are committed to providing the enabling resources for the establishment of Syndicates and then contributing expertise for their on-going management and coordination.